- Home
- MDGL vs LUMN Comparison
MDGL vs LUMN Comparison
Compare MDGL & LUMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MDGL
- LUMN
- Stock Information
- Founded
- MDGL 2011
- LUMN 1968
- Country
- MDGL United States
- LUMN United States
- Employees
- MDGL N/A
- LUMN N/A
- Industry
- MDGL Biotechnology: Pharmaceutical Preparations
- LUMN Telecommunications Equipment
- Sector
- MDGL Health Care
- LUMN Telecommunications
- Exchange
- MDGL Nasdaq
- LUMN Nasdaq
- Market Cap
- MDGL 7.4B
- LUMN 6.3B
- IPO Year
- MDGL N/A
- LUMN 1972
- Fundamental
- Price
- MDGL $321.33
- LUMN $7.95
- Analyst Decision
- MDGL Buy
- LUMN Hold
- Analyst Count
- MDGL 14
- LUMN 8
- Target Price
- MDGL $347.33
- LUMN $3.84
- AVG Volume (30 Days)
- MDGL 654.8K
- LUMN 18.4M
- Earning Date
- MDGL 10-31-2024
- LUMN 11-05-2024
- Dividend Yield
- MDGL N/A
- LUMN N/A
- EPS Growth
- MDGL N/A
- LUMN N/A
- EPS
- MDGL N/A
- LUMN N/A
- Revenue
- MDGL $76,813,000.00
- LUMN $13,296,000,000.00
- Revenue This Year
- MDGL N/A
- LUMN N/A
- Revenue Next Year
- MDGL $193.46
- LUMN N/A
- P/E Ratio
- MDGL N/A
- LUMN N/A
- Revenue Growth
- MDGL N/A
- LUMN N/A
- 52 Week Low
- MDGL $168.25
- LUMN $0.97
- 52 Week High
- MDGL $368.29
- LUMN $10.33
- Technical
- Relative Strength Index (RSI)
- MDGL 62.52
- LUMN 48.43
- Support Level
- MDGL $272.72
- LUMN $7.35
- Resistance Level
- MDGL $323.99
- LUMN $10.33
- Average True Range (ATR)
- MDGL 19.26
- LUMN 0.71
- MACD
- MDGL -2.73
- LUMN -0.18
- Stochastic Oscillator
- MDGL 48.41
- LUMN 20.29
About MDGL Madrigal Pharmaceuticals Inc.
Madrigal Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. It focuses on the development and commercialization of therapeutic candidates for the treatment of cardiovascular-metabolic diseases and non-alcoholic steatohepatitis (NASH). The product portfolio of the company includes MGL-3196, an orally administered, small-molecule liver-directed B-selective THR agonist, which is used for the treatment of non-alcoholic steatohepatitis and familial hypercholesterolemia. Also, MGL-3196 reduces triglycerides in the plasma and liver by increasing fat metabolism and shows an anti-diabetic action.
About LUMN Lumen Technologies Inc.
With 450,000 route miles of fiber, Lumen Technologies is one of the United States' largest telecommunications carriers serving global enterprises. Its merger with Level 3 in 2017 and divestiture of much of its incumbent local exchange carrier, or ILEC, business in 2022 has shifted the company's operations away from its legacy consumer business and toward enterprises (now about 75% of revenue). Lumen offers businesses a full menu of communications services, providing colocation and data center services, data transportation, and end-user phone and internet service. On the consumer side, Lumen provides broadband and phone service across 37 states, where it has 4.5 million broadband customers.